ArticleBiomarker research2026

Serum interleukin-6 (Il-6) monitoring in idiopathic multicentric Castleman disease: important value in patients receiving non-anti-Il-6 therapy.

Zi-Han Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.